Abstract-In aged spontaneously hypertensive rats (SHR), vasorelaxant responses to NO are attenuated compared with normotensive control rats (Wistar-Kyoto [WKY]) because of a decreased expression of the important NO receptor soluble guanylyl cyclase (sGC). Because the expression of sGC subunits ␣ 1 and ␤ 1 is controlled at the posttranscriptional level by the mRNA-binding protein human-antigen R (HuR), we now assessed whether or not altered expression of HuR could account for downregulation of sGC␣ 1 and sGC␤ 1 in genetic hypertension. The expression of HuR (and sGC␣ 1 and sGC␤ 1 ) in aortas from aged SHR was significantly decreased at the mRNA and protein level compared with age-matched WKY rats, whereas expression of HuR was not different in prehypertensive young (2 months of age) SHR and age-matched WKY rats. The mRNA-binding activity of HuR in native aortic protein extracts from aged SHR was markedly reduced compared with normotensive WKY rats, as detected by RNA electrophoretic mobility shift analysis, using biotin-labeled adenine and uracil (AU)-rich element (ARE)-containing RNA probes from the 3Ј-untranslated region of sGC␣ 1 and sGC␤ 1 . In contrast, ARE-binding activity was not different between prehypertensive young SHR and young WKY rats. In vitro RNA degradation assays using the same AU-rich sGC mRNA probes revealed an accelerated sGC␣ 1 and sGC␤ 1 mRNA decay in the presence of native protein extract from hypertensive SHR, which was less rapid with aortic protein from normotensive WKY rats. These findings suggest that in this animal model of genetic hypertension, the reduced expression of sGC subunits is mediated by downregulation of the sGC mRNA-stabilizing protein HuR. Key Words: rats, spontaneously hypertensive Ⅲ aorta Ⅲ gene regulation Ⅲ hypertension, genetic C hronic hypertension is associated with functional and morphological alterations of the vessel wall (ie, dysfunctional vascular endothelium and thickening of the smooth muscle layer). The pathomechanisms accounting for hypertension-induced vascular alterations are likely to be multifactorial. A major homeostatic factor in the vessel wall is NO, which is generated from L-arginine by endothelial NO synthase. NO reduces vascular tone by activation of soluble guanylyl cyclase (sGC) and stimulation of cGMP formation and cGMP-activated protein kinase-I (cGK-I). Activated cGK-I reduces vascular tone by interference with intracellular Ca 2ϩ mobilization 1 and inhibition of contractile filament function. 2 In animal models of hypertension such as the spontaneously hypertensive rat (SHR), disturbances of the NO-cGMP system contribute to vascular dysfunction. Thus, increased oxidative stress interfering with endogenous NO bioavailability and reduced expression of sGC interfering with NO downstream signaling have been reported. 3-5 sGC is a heterodimeric hemoprotein consisting of ␣ 1 (76 to 81.5 kDa) and ␤ 1 (70 kDa) subunits. 6 We have shown recently that the expression of sGC is subject to post-transcriptional regulation. 7 The elav-like (embryonic-lethal abnormal vision) mRNA-binding protein human-antigen R (HuR) stabilizes the sGC␣ 1 mRNA by binding to highly conserved AU-rich elements (AREs; AUUUA) in the 3Ј-untranslated region (3ЈUTR). 7 AREs are targeted for rapid mRNA decay, and thus the presence of AREs within the 3Ј-untranslated region (3Ј-UTR) of numerous mRNAs plays a critical role in regulating mRNA stability and degradation. 8 Understanding of the regulation of HuR activity and expression has emerged only recently. Thus, we have shown that cGMP-and cAMPeliciting agonists decrease HuR expression in rat aortic tissue and cultured rat aortic smooth muscle cells 7, 9 and, at the same time, decrease expression of sGC␣ 1 and sGC␤ 1 subunits. Cyclic nucleotide-induced downregulation of HuR expression occurred via activation of Fos/activator protein-1 transcription factors. 9 These findings indicate that HuR is not only an important factor controlling vascular gene expression, but is also subject to control by vasoactive factors that regulate cGMP and cAMP levels. In the current study, we
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hronic hypertension is associated with functional and morphological alterations of the vessel wall (ie, dysfunctional vascular endothelium and thickening of the smooth muscle layer). The pathomechanisms accounting for hypertension-induced vascular alterations are likely to be multifactorial. A major homeostatic factor in the vessel wall is NO, which is generated from L-arginine by endothelial NO synthase. NO reduces vascular tone by activation of soluble guanylyl cyclase (sGC) and stimulation of cGMP formation and cGMP-activated protein kinase-I (cGK-I). Activated cGK-I reduces vascular tone by interference with intracellular Ca 2ϩ mobilization 1 and inhibition of contractile filament function. 2 In animal models of hypertension such as the spontaneously hypertensive rat (SHR), disturbances of the NO-cGMP system contribute to vascular dysfunction. Thus, increased oxidative stress interfering with endogenous NO bioavailability and reduced expression of sGC interfering with NO downstream signaling have been reported. [3] [4] [5] sGC is a heterodimeric hemoprotein consisting of ␣ 1 (76 to 81.5 kDa) and ␤ 1 (70 kDa) subunits. 6 We have shown recently that the expression of sGC is subject to post-transcriptional regulation. 7 The elav-like (embryonic-lethal abnormal vision) mRNA-binding protein human-antigen R (HuR) stabilizes the sGC␣ 1 mRNA by binding to highly conserved AU-rich elements (AREs; AUUUA) in the 3Ј-untranslated region (3ЈUTR). 7 AREs are targeted for rapid mRNA decay, and thus the presence of AREs within the 3Ј-untranslated region (3Ј-UTR) of numerous mRNAs plays a critical role in regulating mRNA stability and degradation. 8 Understanding of the regulation of HuR activity and expression has emerged only recently. Thus, we have shown that cGMP-and cAMPeliciting agonists decrease HuR expression in rat aortic tissue and cultured rat aortic smooth muscle cells 7, 9 and, at the same time, decrease expression of sGC␣ 1 and sGC␤ 1 subunits. Cyclic nucleotide-induced downregulation of HuR expression occurred via activation of Fos/activator protein-1 transcription factors. 9 These findings indicate that HuR is not only an important factor controlling vascular gene expression, but is also subject to control by vasoactive factors that regulate cGMP and cAMP levels. In the current study, we wished to test whether or not the expression and function of the mRNA-binding protein HuR in rat aorta is affected by genetic hypertension.
Materials and Methods
The antibodies, oligonucleotides, and chemicals for these studies can be found in an online supplement available at http://www.hypertensionaha.org.
Animals
Investigations were performed with isolated aortic rings from 2-month-old prehypertensive and aged (15 to 18 months) hypertensive (SHR) male rats and normotensive age-matched Wistar-Kyoto (WKY) rats (nϭ4 to 6 in each group). For more details about these rats, see the online supplement.
Preparation of the Total Protein From Nuclear and Cytosolic Extracts
For more details on preparation of the total protein from nuclear and cytosolic extracts, see the online supplement.
Construction and Purification of the Glutathione

S-Transferase-HuR Fusion Protein
The plasmid construct pGEX-HuR (generated from pGEX2T) was prepared as described. 10 For the amplification and purification of the glutathione S-transferase (GST)-HuR fusion protein, see the online supplement.
Western Blots
Western blotting of total protein extracts for the detection of HuR, ␣-actin, and sGC subunits was performed as described previously. 7
Reverse Transcription-Polymerase Chain Reaction
The isolation of total RNA from rat aorta and the RT-PCR for HuR, sGC␣ 1 and sGC␤ 1 subunits, and elongation factor II (ef II) mRNA were performed exactly as described previously. 5 Synthesis of sGC␣ 1 and sGC␤ 1 
3-UTR mRNA by In Vitro Transcription
Total RNA of rat aortic tissue was used as a template for RT-PCR amplification of the 3Ј-UTR of sGC ␣ 1 /␤ 1 cDNA regions as described. 7 For more details, see the online supplement.
Electrophoretic Mobility Shift Assay
Electrophoretic mobility shift assays (EMSAs) and supershift assays with total native protein extracts from rat aortic tissue were performed essentially as described. 7 The oligonucleotide sequences can be found in the online supplement.
In Vitro RNA Degradation Assay
More details on the in vitro RNA degradation assay can be found in the online supplement.
Northern Blots
Total RNA samples were fractionated and electroblotted as described previously. 7, 11 For more information, see the online supplement.
Statistics
Where appropriate, data were analyzed for significance of differences using ANOVA. A P value Ͻ0.05 was considered significant. When comparing multiple means, the Bonferroni correction was applied.
Results
Influence of Chronic Hypertension on HuR Expression
To study the influence of long-lasting genetic hypertension on expression of the mRNA-stabilizing protein HuR, endothelium-denuded isolated aortae of young (2 months of age) prehypertensive and old (15 to 16 months of age) hypertensive SHR and age-matched normotensive WKY rats were analyzed. An HuR immunoreactive band migrating at 34 kDa ( Figure 1A ) was identified in all aortae. The expression of HuR protein was significantly decreased (PϽ0.05; nϭ6 to 7 rats; ANOVA) in old SHR compared with age-matched WKY rats ( Figure 1A) . As shown previously, chronic hypertension was also associated with a decrease of both sGC ␣ 1 and ␤ 1 subunits ( Figure 1A ) but did not alter the expression of ␣-actin ( Figure 1A ). The changes in HuR protein expression were accompanied by similar changes in HuR mRNA abundance (PϽ0.05; nϭ3 rats; ANOVA), as shown by RT-PCR ( Figure 1B ) and Northern blotting ( Figure 1C ). In contrast, the protein content ( Figure 2A ) and mRNA expression rate ( Figure 2B ) of HuR were not different in young rats of either strain. However, the protein synthesis of HuR was markedly reduced in old SHR compared with young SHR ( Figure 2C ). Moreover, the content of ef II mRNA was not affected by hypertension ( Figures 1B and 2B ). This finding shows that chronic hypertension in SHR is associated with a significantly decreased expression of HuR in the aorta.
Interaction of Recombinant HuR With the 3-UTR of the sGC␣ 1 and sGC␤ 1 mRNA
As shown in the scheme on the left side of Figure 3 , the 3Ј-UTR of the rat sGC␣ 1 and sGC␤ 1 mRNA contains several conserved AREs (indicated by ), which are targeted for a rapid mRNA degradation by specific endonucleases. 8 Although we demonstrated previously an interaction of endogenous HuR present in cell and tissue extracts with the 3Ј-UTR of the rat sGC␣ 1 mRNA, 7, 9 we now assessed the interaction of GST-tagged recombinant purified HuR with rat sGC␣ 1 and sGC␤ 1 mRNA. Biotin-labeled riboprobes from the 3Ј-UTR of sGC␣ 1 (3UTRSK1) and sGC␤ 1 (␤ 1 -UTR) were incubated for 30 minutes with either GST-HuR fusion protein or recombinant GST (control), and HuR-riboprobe complex formation was detected by RNA EMSA. Both probes migrated as single bands at the bottom (front; Figure 3A and 3B). In the presence of purified GST-HuR fusion protein, the riboprobes were shifted upward ( Figure 3 , shift), indicating a complex formation between HuR and 3UTRSK1 ( Figure 3A ) and ␤ 1 -UTR ( Figure 3B ). Preincubation of HuR with a 100-fold excess of an unlabeled synthetic ARE, [AUUUA] 4 , prevented the complex formation between HuR and 3UTRSK1, indicating a competition between the synthetic ARE and the truncated 3Ј-UTR of sGC␣ 1 mRNA ( Figure 3A ). mRNA-binding activity was not observed with pure GST ( Figure 3A ; nϭ3). Furthermore, the extent of the sGC␤ 1 mRNA band shift seen in Figure 3B was high at low concentrations of HuR and decreased with an increasing amount of HuR added. We assume that an excess of fusion protein shields the biotin label, thereby preventing the streptavidin-horseradish peroxidase reaction for riboprobe detection, or that a nuclease contamination of the GST-HuR preparation destroys the riboprobe at higher concentrations. In summary, HuRbinding activity was detected for both 3Ј-UTRs of the rat sGC␣ 1 and sGC␤ 1 mRNA.
Mutagenesis Analysis of Conserved AREs Within 3-UTR of sGC␣ 1 and sGC␤ 1 mRNA
From the preceding experiments, it was still unclear which nucleotide sequences were responsible for a specific interaction between HuR and these 3Ј-UTR transcripts. To identify specific HuR-binding sites, we chose highly conserved ARE and CU-rich element (CRE) regions of the 3Ј-UTR from sGC␣ 1 . The column diagram shows mean dataϮSEM from densitometric evaluation of 2 blots with 6 different SHR and 7 different WKY rats. *Significant difference (PϽ0.05). B, Ethidium bromide-stained 1% agarose gels of RT-PCR products of HuR mRNA. Aortic RNA (4 g) extracted from tissue was reverse-transcribed and amplified by 38 cycles. ef II was amplified separately as an internal control. Representative data from 2 independent experiments performed with aortas from 3 SHR and 3 WKY rats. "Ϫ" denotes negative control, performed without reverse transcriptase, to exclude a contamination with chromosomal DNA. C, Northern blot showing HuR-mRNA abundance in total denatured RNA (30 g) isolated from the rat aortic tissue. HuR (2.1 kb) and ef II (2.6 kb) mRNA was visualized by chemiluminescence and exposure to x-ray film. The column diagram shows summarized data (mean valueϮSEM) from 3 different old SHR and WKY rats. *Significant difference (PϽ0.05; ANOVA). Figure 4B] ). In contrast, purified GST did not interact with both RNA transcripts (Figure 4) . In control experiments, even a high dose of HuR (400 ng) failed to induce a shift of mismatch riboprobes with mutation of the specific ARE/CRE motifs to GC-rich motifs DR␣ 1 GC3UTR2MIS ( Figure 4A ) and ␤ 1 GC3UTR1MIS ( Figure 4B ). The latter probe showed 2 bands, presumably monomeric and dimeric RNA, independent of the presence or absence of HuR ( Figure 4B ). In summary, the highly conserved AREs/CREs of both 3Ј-UTRs from sGC␣ 1 and sGC␤ 1 mRNA are responsible for a specific binding of HuR.
Comparison of the HuR-Binding Activity in Old SHR and WKY Rats
We then analyzed whether the reduced expression of HuR in hypertensive SHR translated into reduced HuR-binding activity in native protein from rat aorta, using EMSA with sGC mRNA riboprobes DR␣ 1 GC3UTR2 (Figure 5A ) or ␤ 1 GC3UTR1 ( Figure 5B ) as an HuR specific activity assay. In the presence of protein from old WKY rats, a specific band shift signal was observed for DR␣ 1 GC3UTR2 ( Figure 5A) , and 2 signals were detected for ␤ 1 GC3UTR1 ( Figure 5B ). In contrast, with aortic protein from old SHR, the band shift signals with both riboprobes decreased ( Figure 5A and 5B). Addition of a monoclonal HuR antibody to aortic protein from WKY rats (and from young SHR; data not shown) induced a supershift for DR␣ 1 GC3UTR2 ( Figure 5A 
Comparison of Consensus ARE-Like-Binding Activity of HuR in SHR and WKY Rats
To clarify whether the decreased HuR-binding activity for sGC-specific AREs in aged SHR represented total HuRbinding activity, we performed EMSAs with a consensus ARE, [AUUUA] 4 . Incubations without protein served as a control for unbound [AUUUA] 4 . As shown in Figure 6 , the consensus ARE-binding activity of HuR in aortic extracts from old SHR was significantly reduced compared with old WKY rats ( Figure 6A ). In contrast, [AUUUA] 4 -binding activity was not different between young prehypertensive SHR and young WKY rats ( Figure 6B ) or between young and old WKY rats (nϭ4; data not shown). Consequently, reduced 
Degradation of sGC␣ 1 and sGC␤ 1 mRNA by Native Extracts of Aortas From Old SHR and WKY Rats
We then assessed by an in vitro RNA degradation assay whether reduced HuR expression and sGC␣ 1 and sGC␤ 1 mRNA-binding activity in hypertensive SHR accounts for decreased sGC mRNA stability. Total native protein extracts of endotheliumdenuded rat aortas were incubated at 30°C with either biotinlabeled oligoribonucleotide DR␣ 1 GC3UTR2 or ␤ 1 GC3UTR1. After 15, 30, and 45 minutes, RNA degradation was stopped, RNA was separated by denaturing 20% polyacrylamide gel electrophoresis (PAGE)/7 mol/L urea and electroblotted onto nylon membranes (see Materials and Methods). The decay rate of the DR␣ 1 GC3UTR2 ( Figure 7A ) and ␤ 1 GC3UTR1 ( Figure  7B ) mRNA was significantly enhanced by aortic protein from old SHR compared with WKY rats (Figure 7A and 7B) . In contrast, in vitro RNA degradation of the mismatched AREmutated riboprobes DR␣ 1 GC3UTR2MIS and ␤ 1 GC3UTR1MIS was not different between old SHR and WKY rats (data not shown). In summary, these experiments demonstrate an accelerated degradation of ARE-containing and HuR-protected mRNA probes from the 3ЈUTR of sGC subunits by aortic extracts from old SHR.
Discussion
In aged SHR, the NO-vasodilator responsiveness of the aorta is reduced. 3 We recently provided an explanation for this arterial dysfunction by showing that ␣ 1 and ␤ 1 subunits of the NO receptor sGC are downregulated in these animals. 5 We now set out to investigate the molecular mechanism underlying this phenomenon. We decided to focus on a specific post-transcriptional mechanism, which we identified previously to account for cyclic nucleotide-induced downregulation of sGC␣ 1 and sGC␤ 1 subunits in aortic vascular smooth muscle cells and aortic tissue from normotensive rats. 7, 9 This mechanism is based on regulation of mRNA stability by the elav-like protein HuR, 8 which binds to AREs present in the 3Ј-UTR of sGC␣ 1 and sGC␤ 1 mRNA. HuR protects AREcontaining mRNAs from degradation, presumably by preventing the attack of specific endonucleases that are targeted to AREs. 12 We reported that cGMP and cAMP destabilize sGC mRNA by downregulation of HuR expression. 7, 9 
HuR Expression and Activity in Chronic Hypertension
We now show that in aortic tissue from aged SHR, the expression of HuR is decreased by Ͼ50% at the protein and mRNA level compared with normotensive age-matched WKY rats (Figure 1 ). We also confirmed our previous findings that expression of sGC␣ 1 and sGC␤ 1 is decreased to a similar degree in aged SHR (Figure 1 ). In contrast, HuR expression was not different between prehypertensive young SHR and young WKY rats (Figure 2 ). By EMSA, we ascertained that the reduced expression of HuR in aged SHR translated into a similarly reduced binding of HuR present in native aortic protein extract to an ARE-containing 40-nt-sized riboprobe from the 3Ј-UTR of sGC␣ 1 and to a mixed [AUUUA] 4 incubated without protein served as a negative control (C). Representative data from 3 independent experiments performed with aortic protein from 5 young and old SHR and WKY rats.
ARE/CRE containing riboprobe from the 3Ј-UTR of sGC␤ 1 ( Figure 5 ). Using a model ARE, [AUUUA] 4 , 9 we could also show that HuR-binding activity was not different in aortic extract from young SHR and WKY rats (Figure 6 ), in accordance with equal HuR expression in these normotensive rats. Because decreased HuR expression does not necessarily translate into decreased protection of HuR-targeted mRNAs, we assessed the influence of aortic protein on sGC mRNA stability in vitro using the same riboprobes as for EMSA. Indeed, the in vitro degradation of AU-rich sGC mRNAspecific riboprobes during 45 minutes at 30°C was accelerated in the presence of native protein from aortas of aged SHR compared with WKY rats (Figure 7) . Altogether, these findings suggest that chronic hypertension induces changes in HuR expression and activity, which account for decreased sGC expression and activity in the aorta of hypertensive rats.
Specificity of the Interaction of HuR With the 3-UTR of sGC␣ 1 and sGC␤ 1 mRNA
Using affinity-purified GST-tagged recombinant HuR in EMSA experiments, we confirmed our previous observation performed with cell and tissue extracts that HuR binds to a 1.1-kb fragment of the 3Ј-UTR of sGC␣ 1 mRNA containing 6 AREs and to the full-length 3Ј-UTR of the ␤ 1 mRNA containing 7 AREs (Figure 3) . Furthermore, we could demonstrate a specific interaction of recombinant HuR with an ARE-containing 40-nt riboprobe from the 3Ј-UTR of sGC␣ 1 mRNA and with an mixed ARE/CRE-containing probe from the 3Ј-UTR of sGC␤ 1 mRNA (Figure 4) . Mutation of these AREs and CREs resulted in complete loss of HuR binding, indicating the specific requirement of these sequence motifs for HuR recognition of these truncated mRNAs. CREs lacking the AUUUA pentamer were described recently as new HuR targets and were classified as type III AREs. 13 sGC␤ 1 seems to represent another example in which interaction of HuR with a CRE (in addition to interaction with AREs) stabilizes the respective mRNA.
Significance of Downregulation of HuR in Chronic Hypertension
Our present findings suggest that downregulation of sGC expression by downregulation of HuR fulfills intracellular signaling requirements for adaptation of the arterial vascular wall to chronic hypertension. In SHR, vascular remodeling is a complex process leading to different morphological phenotypes in early and late hypertension and in different vascular beds. 14 In the aorta, hypertrophic growth is prevailing in late hypertension. HuR regulates progression of the cell cycle [15] [16] [17] and sGC activation was shown to block progression of the cell cycle in vascular smooth muscle cells. 18 Therefore, it is conceivable that downregulation of HuR and sGC is required for hypertrophic remodeling of the aortic wall. This hypothesis is also supported by the observation that sGC is downregulated during neointima formation in rat carotid artery in response to balloon injury and that adenoviral sGC␣ 1 and sGC␤ 1 gene transfer plus NO donor application prevented neointima formation in this model. 19 Furthermore, altered expression of other HuR-regulated proteins, such as matrix metalloproteinase-9 (MMP-9), 20 the ␤2-adrenergic receptor, 21 angiotensin II type 2 (AT 2 ) receptors, and others, 22 may contribute to this adaptation to chronic hypertension. For instance, MMP-9 was found to be slightly reduced in hearts of hypertensive SHR, 23 and the ␤2-adrenergic and AT 2 receptors are downregulated in several vessel types in chronic hypertension. 24, 25 However, it must be kept in mind that HuR is not the sole trans-acting factor regulating mRNA stability by cisregulatory elements. A prominent opponent of HuR is the mRNA-destabilizing protein AU-rich RNA binding factor-1 (AUF1), which competes with HuR for the same AREs in target mRNAs and facilitates degradation of ARE-targeted mRNAs by specific endonucleases. 22 By Western blot analysis, we detected all 4 AUF1 isoforms (p45, p42, p40, and p37) in aortic tissue from old SHR and WKY rats (S . Klöss  et al, unpublished results, 2003) . We also found that AUF1 proteins can bind to the 3Ј-UTR of sGC␣ 1 and sGC␤ 1 . In vitro RNA degradation of sGC mRNA riboprobes by aortic protein from old SHR and WKY rats. Equal amounts of biotin-labeled riboprobes DR␣ 1 GC3UTR2 (A) and ␤ 1 GC3UTR1 (B; 150 ng) were incubated with native protein (500 to 600 ng) from old SHR and WKY rats for the indicated times at 30°C. RNA products were separated on a denaturing 20% polyacrylamide gel containing 7 mol/L urea. Bottom, Column diagram showing meanϮSEM from densitometric evaluation of 3 experiments performed with aortic tissue from 4 SHR and 4 WKY rats.
However, expression of these AUF1 isoforms was not different between both rat strains (S. Klöss et al, unpublished results, 2003) . According to these findings, we may speculate that the ratio between HuR and AUF1 activity controls sGC mRNA stability and that HuR is the dominating factor in normotensive rat aorta. However, when this ratio decreases, such as in long-lasting hypertension, AUF1-mediated mRNA degradation may take over and lead to sGC mRNA destabilization. Further studies will have to clarify the molecular mechanism accounting for decreased HuR expression in this condition.
Perspectives
We show here that the decrease in sGC␣ 1 and sGC␤ 1 protein expression in aged SHR very likely results from a shorter half life of sGC subunit mRNAs in aged SHR because of downregulation of the mRNA-stabilizing protein HuR. The molecular mechanism underlying reduced HuR expression in this animal model is worth being resolved. We made some suggestions. 7, 9 Our present finding bears multiple implications. Obviously, a consequence of decreased HuR expression is the reduced nitrovasodilator responsiveness observed in the aorta of aged SHR. However, it is conceivable that other cGMP-dependent processes in vascular smooth muscle cells (and other cells) may be affected as well, such as proliferation, hypertrophic remodeling, angiogenesis, and apoptosis, which we did not study here. On the other hand, because HuR controls the mRNA stability of a variety of cardiovascular targets, all these will potentially be affected in this animal model, and the respective alterations in gene expression will constitute the adaptive response to chronic hypertension. This has to be verified in the human system, too. Furthermore, our finding bears on other situations in which HuR and sGC expression are altered in concert, such as in embryonal and postnatal development of different organ systems, and in cell cycle progression. Altogether, this underpins that HuR is a main player in regulation of gene expression at the post-transcriptional level.
